Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma
Trial details
- Registry ID
- NCT01242930
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Revlimid
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple MyelomaNCT01242930 | Geron Corporation | Phase 2 | Completed | 2014-11Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |